In breast cancer, it was found that decreased expression of miR-205 in breast fibroblasts can activate NFs to CAFs by targeting YAP1, especially without the intervention of VEGF, and CAF activation mediated by miR-205 and YAP1 can also promote angiogenesis. Here, YAP1 is linked to breast carcinoma.